ITGR - Integer Holdings Corp Latest SEC Filings
This article provides the latest SEC filing information for Integer Holdings Corp (ITGR), along with a comprehensive overview of its financial performance, key metrics, and trading data. It includes details such as market capitalization, income, sales, P/E ratios, dividend information, insider transactions, institutional ownership, profitability margins, and various stock performance indicators. The data aims to offer a detailed financial snapshot of the company.
Integer Holdings Corporation (ITGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Integer Holdings Corporation (NYSE: ITGR) for alleged corporate wrongdoing. The firm encourages investors who purchased Integer securities before July 25, 2024, and still hold them, to contact them to assist in the investigation. The firm operates on a contingency fee basis, aiming to recover investor capital and ensure corporate accountability.
Integer Announces Conference Call to Discuss Second Quarter 2026 Results
Integer Holdings Corporation announced it will release its second-quarter 2026 financial results on July 25, 2026, before the market opens. The company will host a conference call on the same day at 9:00 a.m. ET to discuss these results. A live webcast and replay of the call will be available on their investor relations website.
Integer Announces Conference Call to Discuss Second Quarter 2026 Results
Integer Holdings Corporation (NYSE: ITGR) announced that it will host a conference call on Thursday, August 6, 2026, at 8 a.m. CT (9 a.m. ET) to discuss its financial results and business highlights for the second quarter ending July 3, 2026. The company will issue a news release announcing its financial results prior to the call. An audio replay will be available for seven days, and the call will also be accessible live and via archived replay on the Investor Relations section of Integer's website.
Integer Holdings schedules Aug. 6 call for Q2 results
Integer Holdings Corporation (NYSE: ITGR) announced it will host a webcast conference call on Thursday, August 6, 2026, at 8 a.m. CT (9 a.m. ET) to discuss its second quarter 2026 financial results and business highlights. The company plans to release its Q2 2026 results earlier that day. Investors can access the call via phone or the company's investor relations website, with an audio replay available for seven days.
Integer Announces Conference Call to Discuss Second Quarter 2026 Results
Integer Holdings Corporation (NYSE: ITGR) announced it will host a webcast conference call on Thursday, August 6, 2026, at 8 a.m. CT (9 a.m. ET) to discuss its financial results and business highlights for the second quarter ended July 3, 2026. The company, a leading global medical device CDMO, will issue a news release with its financial results prior to the call. An audio replay will be available for seven days, and further information is accessible on Integer's Investor Relations website.
Integer Holdings (ITGR) grants 1,096 restricted stock units to senior executive
Integer Holdings Corp (ITGR) announced that John A. Harris, President of Global Operations & Manufacturing Technology, received a grant of 1,096 restricted stock units (RSUs) on June 29, 2026. These RSUs will convert into common stock on a one-for-one basis and are scheduled to vest on December 31, 2027. This transaction is considered routine executive equity compensation and does not involve any open-market buying or selling of shares.
Integer Holdings (NYSE: ITGR) CHRO RSUs vest with share tax-withholding
Integer Holdings Corp's Chief Human Resources Officer, Thor K. Kirk, reported routine equity compensation activity where 6,120 restricted stock units (RSUs) vested and converted into common shares on June 30, 2026. To cover tax obligations, 2,409 shares were withheld, leaving him with 38,693 common shares. This transaction was a standard RSU vesting with no open-market buying or selling involved.
ITGR - Integer Holdings Corp Volatility & Greeks
This article provides a detailed financial overview of Integer Holdings Corp (ITGR), including its stock performance, valuation metrics, earnings per share, sales growth, and institutional ownership. It highlights key financial ratios, volatility indicators, and analyst recommendations, offering a comprehensive snapshot of the company's current market position.
Integer Holdings Corporation(NYSE:ITGR) dropped from Russell Small Cap Comp Growth Benchmark
Integer Holdings Corporation (NYSE:ITGR) has been dropped from the Russell Small Cap Comp Growth Benchmark, as well as the Russell 2500 Growth and Russell 2000 Growth-Defensive and Growth Benchmarks. Simultaneously, the company was added to the Russell 2000 Value Benchmark and Russell 2500 Value Benchmark, indicating a shift in its index classification based on growth versus value metrics. This reclassification happened on June 29, 2026, alongside other recent news including an equity buyback plan update, Q1 2026 earnings beat, and an Oppenheimer upgrade to Outperform.
Integer Holdings Corp adjusts medical portfolio, shares track sector peers
Integer Holdings Corp, a medical device outsource manufacturer, continues to be a key supplier for medical and cardiovascular companies, with its shares trading alongside sector peers like Medtronic and Boston Scientific. The company offers a diversified portfolio of products and maintains strong relationships with major healthcare OEMs. Integer's strategy focuses on deepening client relationships and expanding into adjacent medical technology categories.
Integer Holdings Corporation Actuals & Estimates (SWB:WGB)
This article provides an overview of Integer Holdings Corporation (SWB:WGB), including its stock forecast, financial actuals and estimates, and company information. Analysts’ price targets range from 72.10 EUR to 98.70 EUR, and the company is expected to release its next earnings report on July 23, 2026. The article also details recent earnings, revenue, net income, and EBITDA.
Integer Holdings Announces Executive Role Transition and Compensation
Integer Holdings announced executive role changes and compensation adjustments for Jim Stephens, effective June 29, 2026, transitioning him to Executive Vice President, Special Projects, until March 31, 2027. The company's board committee approved these changes, detailing severance terms and future incentive eligibility. This move provides transparency on leadership succession and governance within the company.
Understanding Momentum Shifts in (ITGR)
This article analyzes Integer Holdings Corporation (NASDAQ: ITGR), noting a potential shift to positive near-term sentiment and a breakout in its stock price. It highlights multiple AI-generated trading strategies with specific entry, target, and stop-loss levels, and provides multi-timeframe signal analysis indicating varying support and resistance levels. The report suggests compelling upside potential as no resistance levels remain above the current price.
Integer Holdings Corp · 8-K
This document is an 8-K filing from Integer Holdings Corp, indicating a departure or appointment of directors or officers. It was filed on June 26, 2026, and is available on SEC.gov.
[8-K] Integer Holdings Corp Reports Material Event
Integer Holdings Corporation (ITGR) has reported a material event via an 8-K filing concerning a change in the role and compensation of Jim Stephens, currently President of Cardiac Rhythm Management & Neuromodulation. Effective June 29, 2026, he will transition to Executive Vice President, Special Projects, a role scheduled to end on March 31, 2027. This change also specifies conditions related to a potential Change of Control and his eligibility for 2027 incentive awards.
Price to book forward of Integer Holdings Corporation – BX:WGB
The article provides a single data point for the "Price to book forward" metric of Integer Holdings Corporation (WGB) on the BX Swiss exchange. The value is listed as "No trades" for the given period and no additional financial details or context are provided.
Price to earnings forward of Integer Holdings Corporation – NYSE:ITGR
The article provides financial information for Integer Holdings Corporation (NYSE: ITGR), specifically focusing on its "Price to earnings forward." It details the company's financial overview, news, documents, and technical data available on TradingView, noting that market data is provided by ICE Data Services and FactSet.
Integer Holdings Corp (ITGR) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Integer Holdings Corp (ITGR), detailing its volatility, financial risk, and investment risk. It highlights the company's current risk assessment score, beta value, and various return and volatility metrics over different periods. The stock ranks 102 out of 203 in the Healthcare Equipment & Supplies industry with a beta of 0.68, indicating it is less volatile than the S&P 500.
Integer Holdings Corporation (ITGR) Stock Analysis: A Closer Look at Its 7.25% Potential Upside
Integer Holdings Corporation (ITGR), a medical device company, shows a potential upside of 7.25% with an average analyst target price of $97.56. The company has a stable upward trend, positive analyst sentiment, and strong cash flow, making it an attractive option for investors focused on capital appreciation despite modest revenue growth and no dividend. Investors are advised to perform due diligence and consider broader market conditions.
ITGR Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial overview of Integer Holdings Corp (ITGR), detailing its revenue breakdown by business segment, with Cardiac Rhythm Management & Neuromodulation being the largest contributor at 59.5% ($261.73M). It also analyzes the company's profitability and margins, including a gross margin of 25.16%, an operating margin of 8.16%, and a net margin of 3.75%, alongside a Return on Equity of 8.58%. Finally, the article compares ITGR's market capitalization and gross margin to competitors HAE and IRTC, highlighting industry benchmarks.
Integer Holdings Corporation (ITGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Integer Holdings Corporation (ITGR) for corporate wrongdoing. The firm encourages investors who purchased ITGR securities before July 25, 2024, and still hold them, to contact them to assist in the investigation. The representation of investors is on a contingency fee basis, meaning no cost to investors unless successful.
Integer Holdings Corp (ITGR) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Integer Holdings Corp (ITGR), detailing its current price momentum score, support and resistance levels, and various technical indicators. It presents a summary of buy, sell, and neutral signals based on indicators like MACD, RSI, and moving averages, concluding with a "Buy" signal based on a combined technical assessment. The analysis suggests suitability for range-bound swing trading given its current price range.
Integer Holdings Corp (ITGR) Financial Health: Profitability & Balance Sheet Analysis
This article analyzes the financial health of Integer Holdings Corp (ITGR), highlighting its current financial score of 7.84, which ranks 61st in the Healthcare Equipment & Supplies industry. The company demonstrated stable financial status and average operating efficiency, with a recent quarterly revenue increase of 0.50% year-over-year and a significant net profit increase of 173.40% year-over-year. The analysis also covers various financial dimensions such as quality of earnings, operational efficiency, growth potential, and shareholder returns, though some specific data were not disclosed.
Integer Holdings Corp (ITGR) Institutional Confidence
Integer Holdings Corp (ITGR) has a strong institutional shareholding score of 10.00, placing it first in its industry. Total institutional shareholding has increased by 10.62% quarter-over-quarter, now standing at 124.18% of shares outstanding. ETHSX is the largest institutional shareholder, holding 1.92% of outstanding shares, marking a significant increase in its holdings.
Integer Holdings Corp (ITGR) Earnings Forecast: Future EPS & Revenue Growth Estimates
Integer Holdings Corp (ITGR) has an earnings forecast score of 7.27, ranking 145th in its industry, with an average analyst price target of $86.00 and expectations for a 7.38% upside. Analysts generally recommend a "Buy" for the stock. The company's expected revenue for the next quarter is $452.16M, and its previous quarter's EPS was $1.39, with an expected $1.41 for the upcoming quarter.
Integer Holdings Corp (ITGR) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Integer Holdings Corp (ITGR), listing major institutional holders like BlackRock, Vanguard, and Dimensional Fund Advisors. It also breaks down shareholder types, institutional shareholding trends over recent quarters, and recent shareholder activity and changes in holdings. Additionally, it identifies several ETFs that include ITGR in their portfolios.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integer Holdings Corporation (ITGR) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Integer Holdings Corporation (ITGR) concerning potential corporate wrongdoing by the company and its officers. The firm is encouraging investors who purchased Integer securities before July 25, 2024, and still hold them, to join the investigation. The goal is to recover investor capital and ensure corporate accountability.
Avoiding Lag: Real-Time Signals in (ITGR) Movement
This article from Stock Traders Daily provides a real-time signal analysis for Integer Holdings Corporation (ITGR), highlighting weak near-term and long-term sentiment. It outlines three distinct AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis emphasizes an exceptional risk-reward short setup and offers institutional-grade tools for real-time signal updates and personalized alerts.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Integer Holdings Corporation (ITGR) And Encourages Shareholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Integer Holdings Corporation (NYSE: ITGR) and its officers/directors. The firm is encouraging shareholders who purchased Integer securities before July 25, 2024, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, aiming to recover investor capital and ensure corporate accountability.
Heartland Advisors Inc. Purchases 202,715 Shares of Integer Holdings Corporation $ITGR
Heartland Advisors Inc. significantly increased its stake in Integer Holdings Corporation by 506.8% in the fourth quarter, acquiring an additional 202,715 shares to bring its total holding to 242,715 shares, valued at $19.0 million. Integer's stock saw a 2.9% dip in Thursday trading, opening at $91.37, despite positive revenue results that topped expectations, even though earnings slightly missed estimates. The company currently holds a consensus "Hold" rating from analysts with a target price of $98.71.
Integer Holdings Corporation (ITGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Integer Holdings Corporation (NYSE:ITGR) concerning potential corporate wrongdoing. The firm is encouraging shareholders who purchased Integer securities before July 25, 2024, and still hold them, to contact them to assist with the investigation. The representation is on a contingency fee basis.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Integer Holdings Corporation (ITGR) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integer Holdings Corporation (ITGR) who bought securities prior to July 25, 2024, and still hold them. The investigation focuses on whether the company's officers and/or directors engaged in corporate wrongdoing. Investors are encouraged to visit the firm's website or contact them for more information and to assist with the investigation, as the firm represents investors on a contingency fee basis.
Integer Holdings Corp stock (US45826J1051): Medical device supplier in focus after latest quarterly
Integer Holdings Corp, a medical device manufacturer, has released its latest quarterly results, drawing attention from US investors. The company, which specializes in components for various medical devices, reported year-on-year revenue growth supported by strong demand in cardiac, vascular, and neuromodulation categories. Management provided updated guidance for the full year, emphasizing ongoing operational improvements and strategic investments in innovation and manufacturing efficiency.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Integer Holdings Corporation (ITGR) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integer Holdings Corporation (NYSE:ITGR). The firm is focusing on investors who bought Integer securities before July 25, 2024, and still hold them. The investigation aims to determine if Integer and its officers engaged in corporate wrongdoing.
A Look At Integer Holdings (ITGR) Valuation After Analyst Optimism And Upcoming MedTech Conference Interest
Integer Holdings (ITGR) is gaining attention due to a recent business review, increasing interest in its medical device portfolio, and upcoming MedTech conference appearances. Despite recent share price gains (8% in 1 month, 21% YTD), the one-year return is down 23%. Analysts consider the stock modestly undervalued, with a fair value estimate of $97.56 against a current price of $92.74, driven by projected cash flows and strategic growth initiatives.
Discipline and Rules-Based Execution in ITGR Response
This article provides an in-depth analysis of Integer Holdings Corporation (NASDAQ: ITGR), highlighting key findings and AI-generated trading strategies. It discusses a potential shift in near-term sentiment, broader weak alignment, and divergent sentiment across different time horizons, suggesting choppy market conditions. The article also outlines specific institutional trading strategies for ITGR, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis.
Bronstein, Gewirtz & Grossman, LLC Encourages Integer Holdings Corporation (ITGR) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Integer Holdings Corporation (ITGR) stockholders who purchased securities before July 25, 2024, and continue to hold them. The investigation focuses on possible corporate wrongdoing by Integer and its officers/directors. The law firm operates on a contingency fee basis, seeking to recover investor capital and ensure corporate accountability.
Integer Holdings 2026 Outlook: Drivers, Risks, Valuation
Integer Holdings (ITGR) has released a revised 2026 outlook, anticipating flat to down 1% organic sales and adjusted earnings per share between $5.83-$6.40, reflecting cautious customer signals and slower ramps of new programs. The company's business mix shows growth in Cardio & Vascular and Cardiac Rhythm Management & Neuromodulation, but new products are creating a near-term drag. Despite a cheaper valuation compared to peers, the company faces challenges with execution, leverage, and the timing of new product adoption, leading to a Zacks Rank #4 (Sell) rating.
Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
Integer Holdings Corporation (NYSE: ITGR), a medical device contract development and manufacturing organization, announced its participation in the Truist Securities 2026 MedTech Conference on June 16, 2026. Members of the executive leadership team will engage in a fireside chat, which will be accessible via webcast on the company's investor relations website. The company is a leading CDMO serving cardio, vascular, neuromodulation, and cardiac rhythm management markets.
Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
Integer Holdings Corporation, a medical device contract development and manufacturing organization, announced its participation in the Truist Securities 2026 MedTech Conference on June 16, 2026. Executive leadership will hold a fireside chat at 10:40 a.m. ET, which will be available via live webcast and replay on the company's investor relations website.
Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
Integer Holdings Corporation, a prominent medical device contract development and manufacturing organization, announced its participation in the Truist Securities 2026 MedTech Conference on June 16, 2026. Members of Integer's executive leadership team will engage in a fireside chat, which will be accessible via a live webcast and replay on the company's investor relations website. The company specializes in serving cardio and vascular, neuromodulation, and cardiac rhythm management markets.
Medical device maker Integer joins Truist MedTech talks June 16
Integer Holdings (NYSE: ITGR) announced its participation in the Truist Securities 2026 MedTech Conference on June 16, 2026. Executive leaders will engage in a fireside chat at 10:40 a.m. ET, with a live webcast and replay available on the company's investor relations website. This follows recent Q1 2026 results and a strategic review, which were more significant catalysts for the stock.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integer Holdings Corporation (ITGR) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into Integer Holdings Corporation (ITGR) for potential corporate wrongdoing. The firm encourages investors who purchased Integer securities before July 25, 2024, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, aiming to recover investor capital and ensure corporate accountability.
ITGR - Integer Holdings Corp Stock Price and Quote
This article provides a detailed stock quote for Integer Holdings Corp (ITGR), including its latest closing price, dollar and percentage change, and extensive financial metrics. It also lists recent analyst actions and news headlines related to the company, covering earnings reports, leadership transitions, conference participations, and legal updates. The insider trading section shows recent transactions by company executives and directors.
ITGR Maintained by Citigroup -- Price Target Raised to $92
Citigroup analyst Joanne Wuensch maintained a Neutral rating on Integer Holdings Corporation (ITGR) while raising the price target from $89.00 to $92.00. The stock is considered 23.2% undervalued according to GuruFocus's GF Value™ and has a strong GF Score™ of 83/100, though insider selling has been observed. Integer Holdings is a key player in medical device component manufacturing within the healthcare sector.
Integer Holdings Enhances Executive Protections Amid Strategic Review
Integer Holdings has approved enhanced change-of-control protections and cash retention bonuses for its CEO and four other senior executives, amidst an ongoing strategic review aimed at maximizing stockholder value. Shareholders also approved a new omnibus incentive plan, elected directors, and ratified the auditor, indicating strong support for current governance. Despite decent financial performance, the company faces temperaments from leverage, subpar cash conversion, and guidance cuts.
Integer Holdings (ITGR) director awarded 1,967 restricted stock units in equity grant
Integer Holdings Corp director James F. Hinrichs was granted 1,967 restricted stock units (RSUs) on May 20, 2026. These RSUs convert into common stock on a one-for-one basis and vest in installments between August 2026 and May 2027. Settlement of the common shares is deferred until Hinrichs separates from service as a director or upon a change in company control.
Integer Holdings (ITGR) director granted 1,967 RSUs in equity award
Integer Holdings Corp director Michael J. Coyle was granted 1,967 restricted stock units (RSUs) as equity compensation, increasing his direct holdings to 3,322 common shares. These RSUs convert into common stock on a one-for-one basis and will vest in equal installments between August 2026 and May 2027. This transaction is classified as a routine grant/award acquisition rather than an open-market purchase.
Director Alvin Jeffers granted 1,967 RSUs at Integer Holdings (ITGR)
Integer Holdings Corp director Alvin Tyrone Jeffers was granted 1,967 Restricted Stock Units (RSUs) on May 20, 2026, which will convert into common stock on a one-for-one basis. These RSUs will vest in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. Following this grant, Jeffers directly holds 4,552 shares of common stock, representing a compensation-related increase in his equity stake.
